Increasing Capacity
Capacity
There is a critical need to empower clinical researchers in Low- and Middle-Income Countries (LMICs) to lead the research response to epidemic infections. We offer a portfolio of research capacity building initiatives to support emerging clinical researchers in exchanging knowledge, gaining confidence in their research and leadership skills, developing local and regional research agendas, and ultimately increasing the international footprint of their institution both within ISARIC and further afield.
Collaboration is at the core of everything we do and our research capacity strengthening programmes focus on reaching out to, and working with a number of regional and international initiatives. Learn more about past and ongoing opportunities.
Clinical Research During Outbreaks (CREDO)
The CREDO training provides trainees with a set of skills to lead the research response in an outbreak, and strengthens the national capacities of LMICs to generate clinical evidence during outbreaks and facilitate networking and the sharing of resources.
Fellowship Programme
Latest news
Children hospitalised with Omicron did not have a higher risk of experiencing long-term health issues compared to other infections, finds latest study
A new study finds that children hospitalised with initial COVID-19 variant showed more signs of dermatological, fatigue, gastrointestinal, sensory, and sleep issues, as well as behavioural and emotional problems
Public health vision led by ISARIC partners aims to tackle Nipah virus
15 January 2024: In a new paper published in The Lancet Infectious Diseases, researchers based in Bangladesh, Oxford and Geneva call for a comprehensive public health framework to counter Nipah virus and other neglected infectious diseases with pandemic potential.
Draft framework for clinical trials seeks public feedback
18 December 2023: The International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) is working with partners to create a framework on endpoint selection for clinical trials for outbreak-prone infectious diseases. This call for a public consultation invites feedback on what the framework does well, what could be improved and the limits of its potential application.